Dyne Therapeutics, Inc. - COM (DYN)

Q1 2017 13F Holders as of 3/31/2017

Type / Class
Equity / COM
Number of holders
166
Total Shares
149M
Shares change
+31.9M
Total reported value, excl. options
$1.17B
Value change
+$246M
Put/Call ratio
0.83
Number of buys
109
Number of sells
-79
Price
$7.86
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.